Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biodesix Inc (NQ: BDSX ) 1.240 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 13 Open 1.240 Bid (Size) 1.200 (20) Ask (Size) 1.240 (5) Prev. Close 1.240 Today's Range 1.240 - 1.240 52wk Range 1.030 - 2.210 Shares Outstanding 78,614,114 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 April 24, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting April 09, 2024 From Biodesix, Inc. Via Business Wire Performance YTD -30.34% -30.34% 1 Month -15.65% -15.65% 3 Month -37.69% -37.69% 6 Month -12.68% -12.68% 1 Year -25.30% -25.30% More News Read More S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher April 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4 March 02, 2024 Via Talk Markets Biodesix: Q4 Earnings Insights March 01, 2024 Via Benzinga Biodesix's Earnings Outlook February 29, 2024 Via Benzinga Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 05, 2024 Via Benzinga Gold Surges Over 1%; Biodesix Shares Plummet April 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March April 05, 2024 Via Benzinga Topics Economy Stocks Exposures Economy US Equities Recap: Biodesix Q3 Earnings November 07, 2023 Via Benzinga Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement April 05, 2024 From Biodesix, Inc. Via Business Wire Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center March 25, 2024 From Biodesix, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session March 01, 2024 Via Benzinga Earnings Scheduled For March 1, 2024 March 01, 2024 Via Benzinga Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights March 01, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference February 26, 2024 From Biodesix, Inc. Via Business Wire Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 February 16, 2024 From Biodesix, Inc. Via Business Wire 3 Penny Stocks to Turn $999 Into $1 Million: January 2024 January 26, 2024 Via InvestorPlace Topics Economy Exposures Economy Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method November 14, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Upcoming Investor Conferences in November November 09, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Third Quarter 2023 Results and Highlights November 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting October 03, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer September 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Upcoming Investor Conferences in September September 05, 2023 From Biodesix, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
